Effect of experimental cardioplegia methods on normal and hypertrophied rat hearts.
The purpose of this study was to evaluate whether the addition of verapamil hydrochloride to oxygenated glucose-rich cardioplegic solution would improve myocardial preservation. The Langendorff preparation of the isolated rat heart was used. Groups of normal (WKY) and hypertrophied (SHR) hearts were treated by five different cardioplegic methods and subjected to 90 or 30 minutes of ischemia at 28 degrees to 29 degrees C and reperfusion at 37 degrees C. The following cardioplegic solutions were used: Group A, cold (16 degrees C) Krebs-Henseleit (KH) glucose free only; Group B, KH with KCL (30 mEq/L) (16 degrees C); Group C, same as B with verapamil (10 microM); Group D, perfusion with oxygenated KH solution containing KCL (30 mEq/L) for 15 minutes prior to ischemia; and Group E, same as D with verapamil (10 microM). Recovery of contraction amplitude, ischemic contracture, coronary perfusate volume, the amount of creatine kinase in the coronary perfusate, heart rate, time of revival, O2 consumption, and ischemic contracture were measured. After 30 minutes of ischemia, we did not find any significant difference among the combinations tested with respect to contraction amplitude recovery. The hearts recovered fully. After 90 minutes of ischemia, we found that the best-protected groups in the normal hearts were Groups D and E. In the hypertrophied hearts, the addition of verapamil to the enhancement solution was harmful. The use of enhancement solution without verapamil prior to ischemia provided the best myocardial protection in the hypertrophied hearts.
Hochhauser
E
E
Department of Thoracic and Cardiovascular Surgery, Tel Aviv Medical Center, Ichilov Hospital, Israel.
Barak
Y
Y
Einav
S
S
Cohen
S
S
Vidne
B
B
D000818:Animals; D006332:Cardiomegaly; D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D003326:Coronary Circulation; D006324:Heart Arrest, Induced / Q000379:methods*; D008297:Male; D009200:Myocardial Contraction; D010477:Perfusion; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013997:Time Factors; D014700:Verapamil / Q000627:therapeutic use*
D002314:Cardioplegic Solutions; D014700:Verapamil